Eyewear refers to devices and accessories worn on the eyes to protect or improve the vision or eyesight. Eyewear is also used as an accessory for fashion or beautification. Spectacles, sunglasses, goggles, and contact lenses are some of the most commonly used eyewear. The main products of eyewear include contact lenses, spectacles, and sunglasses. They are widely available in men, women, and unisex variants. These are distributed through optical stores, independent brand showrooms, online stores, and retail stores. The eyewear market research report is one of a series of new reports from The Business Research Company that provides eyewear market statistics, including eyewear industry global market size, regional shares, competitors with an eyewear market share, detailed eyewear market segments, market trends and opportunities, and any further data you may need to thrive in the eyewear industry. This eyewear market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry. The global eyewear market size grew from $129.77 billion in 2022 to $139.88 billion in 2023 at a compound annual growth rate (CAGR) of 7.8%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The eyewear market size is expected to grow to $188.25 billion in 2027 at a CAGR of 7.7%. The increasing cases of deteriorating eye health are driving the growth of the eyewear market. Eye deterioration refers to losing the ability to see clearly or the emergence of some defects in the eyes. The most prevalent causes of eye deterioration include age-related macular degeneration, cataract, diabetic retinopathy, glaucoma, and prolonged screen usage. The increasing prevalence of eye deterioration will drive significant demand for eyewear as it helps in correcting eye disorders and helps in gaining clear vision. For instance, according to a news release in October 2021 by the World Health Organization (WHO), at least 1 billion people worldwide have near or distant visual impairment that could be prevented or has yet to be addressed. Vision impairment majorly affects people over the age of 50 and the leading causes are untreated cataracts and uncorrected refractive error. Therefore, the increasing cases of deteriorating eye health is expected to boost demand for eyewear during forecast period. Technological advancement is a key trend gaining popularity in the eyewear market. Technological advancements in eyewear such as smart glasses are gaining traction in the market. Smart glass refers to a gadget that places a computer screen/display in front of a person's eyes using appropriate technology to convey data from a background information system. The display can be shown/reflected on the lens of glasses or delivered to the eyesight as a separate component. The smart glasses also come with other smart features such as Bluetooth connectivity, open ear speakers, a fitness tracker, and others. These have a modular design and provide functionalities for convenience and ease for users. The key market players are focusing on offering smart glasses to strengthen their market position. For instance, in January 2022, Titan, an Indian luxury products company introduced its new smart glasses Titan EyeX. Open-ear speakers, touch controls, and fitness tracking systems are the intriguing features of Titan EyeX smart glasses. The Bluetooth v5.2-enabled wearable is compatible with Android and iOS smartphones. The product also includes an inbuilt fitness tracker and is dust and water-resistant. The smart glasses' open-ear speakers also enable voice navigation and warnings during heavy use. In March 2022, Kering Eyewear, an Italy-based luxury eyewear company announced an agreement to acquire Maui Jim Inc for an undisclosed amount. This acquisition is seen as a significant milestone in the company's overall expansion plan, which intends to solidify the label as a prominent high-end eyewear brand. Maui Jim Inc is a US-based sunglasses manufacturing company. Major players in the eyewear market are Luxottica Group SpA, Essilor International, Zeiss International, Johnson & Johnson Vision Care Inc., Bausch & Lomb Inc., Marchon Eyewear Inc., Fielmann AG, HOYA Corporation, De Rigo SpA, Alcon Vision LLC, GKB Opticals Limited, Titan Company Limited, Lenskart Solutions Private Limited, Ronak Optik Private Limited, Prada SpA, and Rayban Sun Optics India Private Limited. North America was the largest region in the eyewear market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in eyewear market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the eyewear market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The eyewear market consists of sales of goggles and blindfolds. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global eyewear market is segmented - 1) By Product: Contact Lenses, Spectacles, Sunglasses 2) By Gender: Men, Women, Unisex 3) By Distribution Channel: Optical Stores, Independent Brand Showrooms, Online Stores, Retail Stores

Sunglasses are glasses with tinted or colored glasses which protect the eyes from sunlight. It helps to eliminate harmful effects on the eyelid, cornea, lens, and retina. Additionally, patients are advised to use sunglasses after some surgical procedures. The main types of sunglasses include non-polarized and polarized. The non-polarized sunglasses refer to sunglasses that are coated with anti-reflecting lenses which allow a person to see into the sky and underwater better than polarized sunglasses. It treats day and night the same and it is used for driving, hiking, golfing, fishing, and any other outdoor activity where glare is a major concern. Non-polarized sunglasses do not block all light the way that polarized sunglasses do. The different designs in sunglasses include aviator/pilot, rectangle, round, square, oval, cat eye, and others. The different types of frames in sunglasses include injected, metal, acetate, and others, and they are distributed through specialty stores, supermarkets & hypermarkets, online, and others. The sunglasses market research report is one of a series of new reports from The Business Research Company that provides sunglasses market statistics, including sunglasses industry global market size, regional shares, competitors with a sunglasses market share, detailed sunglasses market segments, market trends and opportunities, and any further data you may need to thrive in the sunglasses industry. This sunglasses market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global sunglasses market size grew from $15.54 billion in 2022 to $16.47 billion in 2023 at a compound annual growth rate (CAGR) of 6.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The sunglasses market size is expected to grow to $20.63 billion in 2027 at a CAGR of 5.8%. The growing popularity of sunglasses as a fashion product is expected to propel the growth of the sunglasses market. The rise of consumer preference for well-designed and quality products to elevate their outfit and style has boosted the demand for sunglasses. Sunglasses bring instant symmetry to customers’ faces, which increases the perception of their natural beauty. For instance, according to a report published by a nonprofit trade association for manufacturers and suppliers of the optical industry in the USA, The Vision Council in 2021, a whopping 85% of the world’s adult population reports wearing sunglasses, and they mostly use them for sun protection, and some use it as prescription sunglasses with corrective lenses. Therefore, the growing popularity of sunglasses as a fashion product is driving the growth of the sunglasses market. Polarized sunglass-cum-face shield is a key trend gaining popularity in the sunglasses market. A polarized sunglasses-cum-face shield is a type of sunglass with a full-face shield including a polarized lens. A polarized lens is a type of lens that filters out light. The polarized protective face shield is equipped with UV protection that covers the entire face from eyes to chin providing complete protection. This development attempts to set a new fashion trend after the COVID-19 pandemic. For instance, in October 2021, ZGHYBD, a Japanese company launched polarized sunglasses-cum-face shields made with polycarbonate (PC) and is equipped with UV protection. It covers the entire face from eyes to chin and comes with anti-fog, windproof, and dustproof properties. In July 2021, Kering Eyewear, an Italy-based manufactures of luxury eyewear acquired Lindberg for an undisclosed amount. As part of the acquisition, Lindberg will become part of Kering Eyewear and works under Kering Group. This acquisition enables the expansion of Kering Eyewear and perfectly fits with its development strategy with the addition of Lindberg’s portfolio and brand. Lindberg is a Danish-based family-owned eyewear brand that specializes in handmade titanium glasses. Major players in the sunglasses market are Fielmann AG, Marcolin S.p.A. (Marcolin Group), De Rigo Vision S.p.A., Stylrite Optical Industries, Eyevan Inc., Marchon Eyewear, EssilorLuxottica, Luxottica, Charmant, Randolph Engineering, Inc., Stylrite Optical Industries., Maui Jim, Inc., Revo, Xiamen Asa Sunglasses Co, Adidas AG, and Prada. North America was the largest region in the sunglasses market in 2022 and it is also expected to be the fastest-growing region in the forecast period. The regions covered in the sunglasses market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the sunglasses market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The sunglasses market consists of sales of Photochromic glasses, Blue lense glasses, and Anti-reflective lenses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global sunglasses market is segmented - 1) By Type: Non-Polarized, Polarized 2) By Design: Aviator/Pilot, Rectangle, Round, Square, Oval, Cat Eye, Other Designs 3) By Frame Metal: Injected, Metal, Acetate, Other Frame Metals 4) By Distribution Channel: Specialty Stores, Supermarkets & Hypermarkets, Online, Other Distribution Channels

Sunglasses are glasses with tinted or colored glasses which protect the eyes from sunlight. It helps to eliminate harmful effects on the eyelid, cornea, lens, and retina. Additionally, patients are advised to use sunglasses after some surgical procedures. The main types of sunglasses include non-polarized and polarized. The non-polarized sunglasses refer to sunglasses that are coated with anti-reflecting lenses which allow a person to see into the sky and underwater better than polarized sunglasses. It treats day and night the same and it is used for driving, hiking, golfing, fishing, and any other outdoor activity where glare is a major concern. Non-polarized sunglasses do not block all light the way that polarized sunglasses do. The different designs in sunglasses include aviator/pilot, rectangle, round, square, oval, cat eye, and others. The different types of frames in sunglasses include injected, metal, acetate, and others, and they are distributed through specialty stores, supermarkets & hypermarkets, online, and others. The sunglasses market research report is one of a series of new reports from The Business Research Company that provides sunglasses market statistics, including sunglasses industry global market size, regional shares, competitors with a sunglasses market share, detailed sunglasses market segments, market trends and opportunities, and any further data you may need to thrive in the sunglasses industry. This sunglasses market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global sunglasses market size grew from $15.54 billion in 2022 to $16.47 billion in 2023 at a compound annual growth rate (CAGR) of 6.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The sunglasses market size is expected to grow to $20.63 billion in 2027 at a CAGR of 5.8%. The growing popularity of sunglasses as a fashion product is expected to propel the growth of the sunglasses market. The rise of consumer preference for well-designed and quality products to elevate their outfit and style has boosted the demand for sunglasses. Sunglasses bring instant symmetry to customers’ faces, which increases the perception of their natural beauty. For instance, according to a report published by a nonprofit trade association for manufacturers and suppliers of the optical industry in the USA, The Vision Council in 2021, a whopping 85% of the world’s adult population reports wearing sunglasses, and they mostly use them for sun protection, and some use it as prescription sunglasses with corrective lenses. Therefore, the growing popularity of sunglasses as a fashion product is driving the growth of the sunglasses market. Polarized sunglass-cum-face shield is a key trend gaining popularity in the sunglasses market. A polarized sunglasses-cum-face shield is a type of sunglass with a full-face shield including a polarized lens. A polarized lens is a type of lens that filters out light. The polarized protective face shield is equipped with UV protection that covers the entire face from eyes to chin providing complete protection. This development attempts to set a new fashion trend after the COVID-19 pandemic. For instance, in October 2021, ZGHYBD, a Japanese company launched polarized sunglasses-cum-face shields made with polycarbonate (PC) and is equipped with UV protection. It covers the entire face from eyes to chin and comes with anti-fog, windproof, and dustproof properties. In July 2021, Kering Eyewear, an Italy-based manufactures of luxury eyewear acquired Lindberg for an undisclosed amount. As part of the acquisition, Lindberg will become part of Kering Eyewear and works under Kering Group. This acquisition enables the expansion of Kering Eyewear and perfectly fits with its development strategy with the addition of Lindberg’s portfolio and brand. Lindberg is a Danish-based family-owned eyewear brand that specializes in handmade titanium glasses. Major players in the sunglasses market are Fielmann AG, Marcolin S.p.A. (Marcolin Group), De Rigo Vision S.p.A., Stylrite Optical Industries, Eyevan Inc., Marchon Eyewear, EssilorLuxottica, Luxottica, Charmant, Randolph Engineering, Inc., Stylrite Optical Industries., Maui Jim, Inc., Revo, Xiamen Asa Sunglasses Co, Adidas AG, and Prada. North America was the largest region in the sunglasses market in 2022 and it is also expected to be the fastest-growing region in the forecast period. The regions covered in the sunglasses market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the sunglasses market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The sunglasses market consists of sales of Photochromic glasses, Blue lense glasses, and Anti-reflective lenses. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global sunglasses market is segmented - 1) By Type: Non-Polarized, Polarized 2) By Design: Aviator/Pilot, Rectangle, Round, Square, Oval, Cat Eye, Other Designs 3) By Frame Metal: Injected, Metal, Acetate, Other Frame Metals 4) By Distribution Channel: Specialty Stores, Supermarkets & Hypermarkets, Online, Other Distribution Channels

Dry eye medication refers to the drugs or medication that is used to treat dry eye by increasing your eye moisture. A multifactorial condition of the tears and ocular surface known as dry eye causes symptoms such as pain, blurred vision, and tear film instability, as well as the possibility of ocular surface injury. The main types of dry eye medication are aqueous dry eye syndrome and evaporative dry eye syndrome. Dry eye syndrome is a frequent problem that arises when the tears aren't able to keep the eyes lubricated enough. Tears may be insufficient and unstable for a variety of causes. The different types of products include liquid drops, gel, liquid wipes, and eye ointment and are used by hospital pharmacies, eye health clinics, retail pharmacies, and online pharmacies. The dry eye medication market research report is one of a series of new reports from The Business Research Company that provides dry eye medication market statistics, including dry eye medication industry global market size, regional shares, competitors with a dry eye medication market share, detailed dry eye medication market segments, market trends and opportunities, and any further data you may need to thrive in the dry eye medication industry. This dry eye medication market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global dry eye medication market size will grow from $8.67 billion in 2022 to $9.62 billion in 2023 at a compound annual growth rate (CAGR) of 11.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global dry eye medication market size is expected to grow to $13.99 billion in 2027 at a CAGR of 9.8%. The increased number of cases of dry eye disease results in an increased demand for its treatment. Factors such as aging, lack of vitamin A, wearing lenses, eye surgeries, direct contact with dry wind or smoke, and exposing one’s eyes to screens for a long duration increase the occurrence of the dry eye more likely. For example, a survey conducted by the American Academy of Ophthalmology reported that in the USA, nearly 3.2 million women and 1.68 million men, over the age of 50 were affected by dry eye syndrome. Similarly, a study conducted by the Indian Journal of Ophthalmology indicated a 32% prevalence of dry eye disease in the Northern part of India. the rising prevalence of the disease would increase the demand for its treatment and ultimately facilitate the growth of this market. The market for dry eye medication is restricted by the long approval process that is undertaken before any drug is approved by the concerned authority. The standard protocol for testing any new drug demands a series of tests and trials including laboratory tests, animal model tests, and clinical trials. Most drugs fail during clinical trials and only a small percent of them successfully move forward. The cumbersome process of obtaining approvals takes a longer duration of time and restricts the growth of this market. For example, in 2020, Eysuvis, a drug that addresses the short-term treatment needs of patients living with dry eye disease, was approved by the Food and Drug Administration (FDA) after its safety and effectiveness were assessed on more than 2900 patients with the disease in different clinical trials. Similarly, Kissei Pharmaceutical announced to discontinue the development of the KCT-0809 drug after it failed to pass the 3rd phase of clinical trials. Treatment for dry eye disease improved with the incorporation of modern techniques that helped invent advanced hyaluronic acid-based lubricants and lipid emulsions. This technology replaces artificial tears that include isotonic sodium chloride and provides long-lasting lubrication on the surface of the eye. For instance, Allergan, a global pharmaceutical company, launched Refresh Repair Lubricant Eye Drops which are designed to repair and protect the eyes from dry eye disease and improve the clarity of vision and are formulated with carboxymethylcellulose (CMC), hyaluronic acid, and osmoprotectants. These components maintain the health of the ocular surface and safeguard epithelial cells. Advances in technology will have a positive effect on the market. The dry eye medication market is strictly regulated by government agencies such as USFDA (Food and Drug Administration), the European Medicines Agency (EMA), and others. For instance, in the USA, FDA evaluates and approves the drugs meant for dry eye treatment. According to Section 201(g) of the FDA and CFR (Code of federal regulations) act, the licenses are granted to drug manufacturing companies allowing them to sell only those drugs that are safe and clinically effective. FDA demands several tests and several clinical trial rounds before granting such approvals. For example, FDA approved Kala Pharmaceuticals’ eye-related drug called INVELTYS. In July 2022, Alcon, a Switzerland-based ophthalmology company acquired Eysuvis pharmaceutical eye drops from Kala Pharmaceuticals for a deal amount of $60 million. Through this acquisition, Alcon acquires Inveltys treatment of post-operative inflammation and pain following ocular surgery and expands its portfolio. Kala Pharmaceuticals is a US-based pharmacuetical company operating in drug eye medication. Major players in the dry eye medication market are Novartis, Allergan, Otsuka, Santen Pharmaceutical, Auven Therapeutics, Akorn, Valent Pharmaceuticals, Johnson and Johnson Vision, Alcon and Bausch & Lomb. North America was the largest region in the dry eye medication market in 2022. Middle East is expected to be the fastest-growing region in the global dry eye medication market during the forecast period. The regions covered in the global dry eye medication market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa. The countries covered in the dry eye medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA. The dry eye medication market consists of sales of polyethylene glycol, polyvinyl alcohol, propylene glycol, carboxymethylcellulose, povidone, glycerine, and mineral oil. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global dry eye medication market is segmented - 1) By Type: Aqueous dry eye syndrome, Evaporative dry eye syndrome 2) By end-user: Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies 3) By Product Type: Liquid Drops, Gel, Liquid Wipes, Eye Ointment

Ophthalmology is a branch of science that deals with the structure, function of eyes. Ophthalmic devices are used in the diagnosis and treatment of eye related diseases. The main types of ophthalmic devices are vision care devices and equipment, cataract surgery devices and equipment, refractive surgery devices and equipment, and diagnostic and monitoring ophthalmic devices and equipment. Cataract surgery devices and equipment are devices that emit ultrasound waves that soften and break up the lens so that it can be removed by suction. The type of expenditure is public and private. The products used are instruments/equipment and disposables. The various end uses involved are hospitals and clinics, diagnostic laboratories, and others. The ophthalmic devices market research report is one of a series of new reports from The Business Research Company that provides ophthalmic devices market statistics, including ophthalmic devices industry global market size, regional shares, competitors with a ophthalmic devices market share, detailed ophthalmic devices market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic devices industry. This ophthalmic devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global ophthalmic devices market grew from $36.36 billion in 2022 to $39.24 billion in 2023 at a compound annual growth rate (CAGR) of 7.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The ophthalmic devices market is expected to grow to $51.12 billion in 2027 at a CAGR of 6.8%. The femtosecond laser is increasingly being used in cataract surgeries as it provides greater precision than traditional surgical methods. A femtosecond laser emits optical pulses with a duration of below 1 ps (ultrashort pulses), i.e., in the domain of femtoseconds (1 fs = 10-15 s). The medical procedure using this laser is done under computer-guided OCT imaging, hence there is higher control and reliability of the incisions concerning size, shape, and location than conventional procedures. This process also reduces the risk associated with a human error during the surgery and has a shorter recovery period. Major companies manufacturing femtosecond laser ophthalmic equipment are Myalcon and Precision Lens. Robotic-assisted eye surgeries are being widely used by healthcare service organizations to improve treatment outcomes. Robot-assisted surgeries allow surgeons to perform complex eye operations with improved precision, amplified scale of motion, reduced tremor, task automation, and flexibility. For instance, the mechatronics and control laboratory and the Jules stein eye institute together developed an intraocular robotic interventional and surgical system (IRISS) which is capable of performing both anterior and posterior intraocular surgery. This system consists of master surgical manipulators to manipulate two surgical instruments simultaneously through tiny ocular incisions and microscope-mounted cameras for 3-D teleoperated surgical visualization. Preceyes BV also developed PRECEYES Surgical System to perform robot-assisted operations inside the eye. Major companies in the ophthalmic devices market include Luxottica Group S.p.A., Johnson & Johnson, Hoya Corporation, CooperVision AG, Bausch Health, Companies Inc., Carl Zeiss AG, Flex Ltd., Nidek Co. Ltd., Topcon Corporation, and Rostec State Corporation. North America was the largest region in the global ophthalmic devices market in 2022. Asia-Pacific was the second largest region in the global ophthalmic devices market. Africa. was the smallest region in the global ophthalmic devices market. The regions covered in the ophthalmic devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the ophthalmic devices market are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa., South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, and Vietnam. The ophthalmic devices consist of sales of instruments such as optical coherence tomography scanners, perimeters/visual field analyzers, ophthalmic pachymeters, wavefront aberrometers, and others. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global ophthalmic devices market is segmented - 1) By Type: Vision Care Devices And Equipment, Cataract Surgery Devices And Equipment, Refractive Surgery Devices And Equipment, Diagnostic And Monitoring Ophthalmic Devices And Equipment 2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users 3) By Type of Expenditure: Public, Private 4) By Product: Instruments/Equipment, Disposables

Ophthalmic medical lasers are used in the treatment of diseases related to the eye. The main products of the ophthalmic medical lasers are diode lasers, femtosecond lasers, excimer lasers for aromatherapy, ND:YAG lasers, and others. A diode laser is a semiconductor that produces coherent radiation with the same frequency and phase, either in the visible or infrared spectrum, using a p-n junction.The various applications include refractive error correction, cataract removal, diabetic retinopathy, glaucoma, age-related macular degeneration, and others. The various end-users are hospitals, specialty clinics, and ambulatory surgery centres. The ophthalmic medical lasers market research report is one of a series of new reports from The Business Research Company that provides ophthalmic medical lasers market statistics, including ophthalmic medical lasers industry global market size, regional shares, competitors with a ophthalmic medical lasers market share, detailed ophthalmic medical lasers market segments, market trends and opportunities, and any further data you may need to thrive in the ophthalmic medical lasers industry. This ophthalmic medical lasers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global ophthalmic medical lasers market grew from $1.12 billion in 2022 to $1.2 billion in 2023 at a compound annual growth rate (CAGR) of 7.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The ophthalmic medical lasers market is expected to grow from $1.55 billion in 2027 at a CAGR of 6.5%. The rising incidence of ocular disorders is driving the demand for the ophthalmic medical lasers market. Ocular disorders are the ones that affect vision and eye health in patients of all ages and treatment with lasers helps reshape the eye cornea for better focus, which contributes to an improved vision. According to a study by the lancet, in 2020, 43.3 million people were blind. 295 million people had moderate to severe vision impairment, 258 million had mild vision impairment. The rise in the incidence of ocular disease that requires laser treatment contributes to the growth of the ophthalmic medical lasers market. The availability of alternative therapies for vision correction is expected to hinder the ophthalmic medical lasers market. The alternatives for lasers in ophthalmology include using a lens for correcting the vision using techniques such as Phakic Intraocular Lens Implants, and Refractive Lens Exchange Surgery. According to the statistics by the American Society of Cataract and Refractive Surgery (ASCRS), 95% of patients who choose to have a standard IOL procedure, which is considered safe for cataract surgery, experience fully restored vision. Therefore, the availability of alternative therapies to correct vision is expected to hamper the ophthalmic medical lasers market. Companies are investing in manufacturing devices that incorporate next-generation technology to treat ocular diseases. Following the trend, In Feb 2020, IRIDEX Corporation, an innovative ophthalmic laser-based medical products provider for the treatment of glaucoma and retinal diseases has launched the second generation of the MicroPulse P3® Device that gives greater stability, visualization, coupling, and fit. In June 2020, Lumibird, a leading France-based laser technology specialist acquired all of Ellex's laser and ultrasound activities for $70 million. Through this acquisition, the Lumibird group aimed to strengthen its current product portfolio with complementary high-quality products, and extend its geographical presence, particularly in the US and Japan, as the acquisition included Ellex’s R&D and production site in Adelaide and the commercial subsidiaries based in Australia, Japan, the US, France, and Germany. Ellex is a leading Australia-based ophthalmic equipment manufacturer. Major players in the ophthalmic medical lasers market are Alcon Laboratories Inc., Abbott Medical Optics Inc., Carl Zeiss Meditec AG, Bausch & Lomb Incorporated, Topcon Corporation, Ziemer Ophthalmic Systems AG, IRIDEX Corporation, and NIDEK Co. Ltd., Lumenis Ltd., and Johnson & Johnson. North America was the largest region in the ophthalmic medical lasers market in 2022. Asia-Pacific was the second largest region in the global ophthalmic medical lasers market report. The regions covered in the global ophthalmic medical lasers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the ophthalmic medical lasers market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA. The ophthalmic medical lasers market consists of sales of instruments such as SLT lasers, excimer lasers, cyclodiode lasers, and femtosecond lasers. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products. The global ophthalmic medical lasers market is segmented - 1) By Product: Diode Lasers, Femtosecond Lasers, Excimer Lasers Aromatherapy, ND:Yag Lasers, Other Products 2) By End User: Hospitals, Specialty Clinics and Ambulatory Surgery Centres 3) By Application: Refractive Error Correction, Cataract Removal, Diabetic Retinopathy, Glaucoma, Age-Related Macular Degeneration, Other Applications

Diagnostic and monitoring ophthalmic devices and equipment are used for the diagnosis and monitoring of diseases related to the retina and cornea by measuring affix lenses and refractive errors. These devices also help identify the intraocular lenses (IOLs) and analyze the visual field. The main product types in the diagnostic and monitoring ophthalmic devices and equipment are optical coherence tomographers, ophthalmic ultrasound imaging systems, fundus cameras, ophthalmoscopes, keratometers, specular microscopes., tonometers, slit lamps, retinoscopes, and others (dioptometers, optotype projector, perimeters, and biometers, pachymeters, autorefractors/phoropters, corneal topographers, wavefront aberrometer, wavefront aberrometer). Fundus cameras are used for diagnosing and monitoring and are used in imaging of a rear eye. These are used in various applications such as retinal evaluation, glaucoma detection, and monitoring, surgical evaluation, general examination, intraoperative devices, and refraction equipment. The diagnostic and monitoring ophthalmic devices are used in hospitals, clinics, diagnostic laboratories, and research centres. The diagnostic and monitoring ophthalmic devices and equipment market research report is one of a series of new reports from The Business Research Company that provides diagnostic and monitoring ophthalmic devices and equipment market statistics, including diagnostic and monitoring ophthalmic devices and equipment industry global market size, regional shares, competitors with a diagnostic and monitoring ophthalmic devices and equipment market share, detailed diagnostic and monitoring ophthalmic devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic and monitoring ophthalmic devices and equipment industry. This diagnostic and monitoring ophthalmic devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry. The global diagnostic and monitoring ophthalmic devices and equipment market size will grow from $2.5 billion in 2022 to $2.72 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The diagnostic and monitoring ophthalmic devices and equipment market size is expected to grow from $3.6 billion in 2027 at a CAGR of 7.3%. The increasing prevalence of eye diseases is expected to drive the demand for diagnostic and monitoring equipment in the ophthalmic devices industry. The rise in surgeries associated with eye disorders like cataracts, diabetic retinopathy, and glaucoma has increased the demand for diagnostic and monitoring ophthalmic devices. According to a study, 4 out of 10 people have been found to have cataract disease in their early stages of life. The absolute number of cataract blind in 2020 would be 8.25 million, due to a substantial increase in the population above 50 years in India. Lack of awareness about eye diseases mostly in developing and underdeveloped nations is expected to hinder the growth of the diagnostic and monitoring ophthalmic devices and equipment market. BLack of awareness of eye disorders results in fewer patients going for a routine eye check-up or diagnosis of the disorder, impacting the demand for diagnostic and monitoring ophthalmic equipment. According to a study conducted by the vision impact institute, 42% of drivers in India have vision-related problems leading to 59% of road accidents. According to WHO, 550 million people in the country need vision correction and to achieve this, companies should increase awareness & provide vision care to people living in rural and semi-urban areas. Advanced eye care medical devices equipped with artificial intelligence (AI) and machine learning (ML) are the new trends in the ophthalmic diagnostic and monitoring equipment market. AI and ML-equipped medical devices can not only quickly interpret the eyes of the patient with better accuracy but also recommend a suitable treatment for the patient. Deepmind, a subsidiary of Alphabet Inc. has developed an AI-based system that is capable of analyzing 3D retinal OCT scans for detecting severe diseases like glaucoma, retinopathy, macular degeneration, and 50 different types of eye diseases at their early stage. The increased regulatory compliance norms by the Food and Drug Administration (FDA) and the Medicines and Healthcare products Regulatory Agency (MHRA) have impacted the market making the approval/regulation process for diagnostic and monitoring ophthalmic devices strenuous. Complex and tedious premarket and postmarket submissions by FDA may increase the product release time and incur heavy costs on device development. The MHRA considers a medical device to be any equipment used for the diagnosis or treatment of disease, or for monitoring patients and recommends Yellow card reporting for ophthalmic devices and products as well. All the adverse events and the causes for any untoward incidents must be reported in the yellow card, allowing the equipment to be monitored thoroughly for enhanced patient safety. In July 2020, Topcon, a company manufacturing optical equipment based in Japan acquired Elektron Eye Technology for an undisclosed amount. This acquisition includes the products of the Henson line of perimetry such as Henson 9000 and 7000 that perform suprathreshold glaucoma screening and the product manufacturing will remain in the UK. Elektron Eye Technology is a company operating in the diagnostic and monitoring of ophthalmic devices based in the UK. Major players in the diagnostic and monitoring ophthalmic devices and equipment market are Carl Zeiss Meditec, Alcon, Bausch + Lomb, Haag-Streit, Topcon Corporation, Nidek Co. Ltd., Abbott Medical Optics, Johnson and Johnson Vision Care, Essilor International S.A, and Ziemer Ophthalmic Systems AG. North America was the largest region in the global diagnostic and monitoring ophthalmic devices and equipment market in 2022. Asia-Pacific was the second largest market in diagnostic and monitoring ophthalmic devices and equipment market. The regions covered in the global diagnostic and monitoring ophthalmic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the diagnostic and monitoring ophthalmic devices and equipment market are Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, and Australia. The Diagnostic and monitoring ophthalmic devices and equipment market consist of sales of ultrasound imaging systems ophthalmoscopes, corneal topographers, specular microscopes, slit lamps, fundus cameras, anomaloscope, haploscope, ophthalmic lens gauge, stereopsis measuring Instrument, retinoscopes, stereoscope, and others that are used for diagnosis and monitoring of ophthalmic diseases. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products. The global diagnostic and monitoring ophthalmic devices and equipment market is segmented - 1) By Product Type: Optical coherence tomographers, Ophthalmic ultrasound imaging systems, Fundus cameras, Ophthalmoscopes, Keratometers, Specular microscopes., Tonometers, Slit Lamps, Retinoscopes, Others(Dioptometers, Optotype projector, Perimeters, and Biometers,Pachymeters,Autorefractors/phoropters,Corneal topographers,Wavefront abberometers,Wavefront abberometers) 2) By End User: Hospitals, Clinics, Diagnostic Laboratories, Research Centers 3) By Application: Retinal evaluation, Glaucoma detection and monitoring, Surgical evaluation, General examine, Intraoperative devices, Refraction equipment

The ophthalmology drugs market consists of sales of ophthalmology drugs and related services by entities (organizations, sole traders and partnerships) that produce ophthalmology drugs to treat eye related diseases. The ophthalmology drugs industry includes establishments that produce pharmaceutical drugs to treat glaucoma diseases, anti- inflammatory and tear stimulating drugs under dry eye medications drugs, and other drugs for treating retinal disorders and allergies. Some of the major ophthalmic drugs include Eylea, Lucentis, Restasis, Vigamox, Azopt, and Lotemax. The main types of ophthalmology drugs are antiglaucoma drugs, dry eye medication, and other ophthalmological drugs (retinal disorders, anti-infectives/allergy). Anti-glaucoma drugs are medications used to prevent or treat glaucoma, which is a disease in which the optic nerve is damaged, resulting in progressive, irreversible vision loss. The drugs are administered through oral, parenteral, and others that are classified into branded and generic drugs. The various mode of purchase includes prescription-based drugs and over-the-counter drugs which are distributed by hospital pharmacies, retail pharmacies/ drug stores and others. The global ophthalmology drugs market size is expected to grow from $50.62 billion in 2021 to $56.07 billion in 2022 at a compound annual growth rate (CAGR) of 10.8%. The growth in the market is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The ophthalmology drugs market is expected to reach $127.15 billion in 2026 at a CAGR of 22.7%. The expected rise in eye laser surgeries will contribute to the ophthalmology drugs market. Ophthalmology research has proved a link between laser eye surgeries and the prevalence of dry eye disorders. In an eye laser procedure, cutting of some nerves in the cornea leads to reduction in corneal sensitivity, in response to which, eyes may not sense the need for lubrication, causing the body to produce fewer tears. Dry eye is a common side effect after laser vision correction surgeries. It is estimated that almost half of the patients that undergo a laser surgery experience some degree of dry eye condition following the procedure. The number of eye laser procedures rose to 720,000 a year in 2020. A rising number of people going for laser eye surgeries is expected to increase the demand for dry eye medications in the forecast period driving the ophthalmology drugs market. Regulatory changes are likely to lead to increased costs relating to new product development and service offerings to clients. These changes are related to data protection such as the European Union's General Data Protection Regulation (GDPR), changes to drug approval procedures and other regulatory changes. For instance, according to a study on 100 Data Privacy and Data Security statistics for 2020, GDPR compliance is a top priority for 58% of European companies. The GDPR regulation is a EU law on data protection and privacy of individuals residing the European Union and the European Economic Area (EEA). It also regulates data anonymization thus maintaining integrity of data dealing with patients and other clinical trial studies. The potential loss of revenue due to delays in product release and additional costs incurred due to stringent approval processes puts strain to investments relating to new product development, thereby affecting the growth of the ophthalmology drugs market. Drug manufacturers are increasingly developing ophthalmic drugs with anti-inflammatory agents to ease patient treatment for dry eye syndrome. Anti-inflammatory drugs are widely used for the treatment of the inflammation produced by the dry eye syndrome, with the topical corticosteroid drops being the most common therapy. Corticosteroids can rapidly and effectively relieve the symptoms and signs of moderate or severe dry eye. However, prolonged usage of corticosteroids has seen to produce side effects that include risk of bacterial or fungal infection, elevated intraocular pressure and cataract formation. As a consequence, NSAIDs are increasingly being used as dry eye treatment instead of steroids to minimize the side effects. For instance, Aciex Therapeutics, a US-based pharmaceutical company, is developing NSAIDs which decrease ocular discomfort. Major companies in the ophthalmology drugs market include Regeneron Pharmaceuticals, Inc., Novartis AG, AbbVie, Santen Pharmaceutical Co., F. Hoffmann-La Roche Ltd., Bausch Health Companies Inc., Bayer AG, Sumitomo Chemical Co ltd, Mitsubishi Tanabe Pharma Corporation and Horizon Therapeutics plc. North America was the largest region in the ophthalmology drugs market in 2021. The Middle East is expected to be the fastest growing region in the forecast period. The regions covered in the ophthalmology drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the ophthalmology drugs market report are Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela and Vietnam. The global ophthalmology drugs market is segmented - 1) By Type: Antiglaucoma Drugs, Dry Eye Medication, Other Ophthalmological Drugs (Retinal Disorders, Anti-Infectives/Allergy) 2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others 3) By Route of Administration: Oral, Parenteral, Others 4) By Drug Classification: Branded Drugs, Generic Drugs 5) By Mode of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs